Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

566 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-19

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to investigate whether pre- and postoperative treatment with systematic PEP therapy can prevent hospital-acquired pneumonia in patients with hip frac-ture. It will also learn about the barriers regarding PEP therapy in this group of patients.

* Does pre- and postoperative treatment with systematic PEP therapy prevent hospital-acquired pneumonia in patients with hip fracture?
* Which barriers do participants have regarding PEP therapy in this group of patients? Researchers will compare systematic PEP therapy to no intervention besides standard treat-ment to see if systematic therapy with PEP can prevent hospital-acquired pneumonia.

Participants will:

* Receive systematic PEP therapy during hospitalization or no intervention besides standard treatment
* Register the PEP therapy four times daily on a paper checklist. Failure to perform the treatment and the reason must also be documented on the checklist.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intensified In-hospital Physiotherapy for Patients After Hip Fracture Surgery.

NCT04804527

Hip Fractures

COMPLETED NA

Observation and Progressive Strength Training After Hip Fracture

NCT01129219

Exercise

UNKNOWN NA

Training of Patients With Hip Fracture

NCT01174589

Hip Fracture

COMPLETED PHASE2

Ultrasound Assessment of Heart and Lungs for Hip Fracture Procedure

NCT03275129

Hip Fractures

COMPLETED NA

Improving Functional Recovery After Hip Fracture

NCT00000436

Unilateral Hip Fracture

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fractures (ICD-10 72.01-72.2)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active

Medical therapy device

Group Type ACTIVE_COMPARATOR

positive expiratory pressure

Intervention Type DEVICE

PEP therapy

Standard treatment

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

positive expiratory pressure

PEP therapy

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hip fracture regardless of age
* Cognitively well-functioning
* Able to understand the study and give informed consent
* Able to speak and understand Danish
* Resident of Region Hovedstaden or Region Sjælland

Exclusion Criteria

* Cognitively impaired
* Unable to understand the study and give informed consent
* Pneumonia upon admission
* Delirium upon admission
* Pneumothorax

For patients with e.g. dementia or brain injury, the ability to give informed consent will be assessed individually.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No